BDTX 8-K 2026-06-29

Black Diamond Therapeutics, Inc. (BDTX) 8-K dated 2026-06-29 — accession 0001104659-26-078847. This URL is the filing, not the BDTX hub.

Black Diamond Therapeutics, Inc. (BDTX) is a biotechnology company listed on NASDAQ.

Black Diamond Therapeutics, Inc. filed a 8-K on 2026-06-29. Accession 0001104659-26-078847.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BDTX revenue for 2026-06-30 was $0. Net income was -$18.9M. BDTX currently screens at market cap $95.7M.

Not investment advice. The BDTX SEC hub lists recent forms. The stock page is the research view.